Cargando…
Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
BACKGROUND: Paraoxonase-1 (PON1) is an antioxidant enzyme that attenuates the production of the monocyte chemoattractant protein-1 (MCP-1) in vitro. Although oxidation and inflammation are closely related processes, the association between PON1 and MCP-1 has not been completely characterised due, pr...
Autores principales: | Parra, Sandra, Marsillach, Judit, Aragonès, Gerard, Rull, Anna, Beltrán-Debón, Raúl, Alonso-Villaverde, Carlos, Joven, Jorge, Camps, Jordi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852375/ https://www.ncbi.nlm.nih.gov/pubmed/20334696 http://dx.doi.org/10.1186/1476-511X-9-32 |
Ejemplares similares
-
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010) -
PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways
por: Camps, Jordi, et al.
Publicado: (2012) -
Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes
por: Alonso-Villaverde, Carlos, et al.
Publicado: (2009) -
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009) -
Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism
por: Aragonès, Gerard, et al.
Publicado: (2011)